Brinker Capital Investments, LLC Bio Techne Corp Transaction History

Brinker Capital Investments, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 13, 2020	SELL	$161.17 - $221.51 $30,622 - $42,086	-190 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$188.72 - $215.43 $2,830 - $3,231	15 Added 8.57%	190 $40,000
Q1 2019 May 14, 2019	SELL	$136.09 - $200.44 $23,543 - $34,676	-173 Reduced 49.71%	175 $35,000
Q2 2018 Aug 14, 2018	SELL	$144.9 - $165.58 $7,534 - $8,610	-52 Reduced 13.0%	348 $51,000
Q2 2017 Aug 08, 2017	BUY	N/A	400	400 $47,000

603

151M

195K

53.2K

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.62B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

Get notified when there are updates to the investment portfolio of Brinker Capital Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Brinker Capital Investments, LLC with notifications on news.